(Q46244481)

20 December 2017

title

Cerebrospinal fluid levels of tau phosphorylated at threonine 181 in patients with Alzheimer's disease and vascular dementia (English)

1 reference

20 December 2017

0 references

0 references

0 references

0 references

8

1 reference

20 December 2017

Arrigo Moglia

7

object named as

Arrigo Moglia

1 reference

20 December 2017

author name string

Sabrina Ravaglia

1

1 reference

20 December 2017

Paola Bini

2

1 reference

20 December 2017

Elena Sinforiani

3

1 reference

20 December 2017

Diego Franciotta

4

1 reference

20 December 2017

Elisabetta Zardini

5

1 reference

20 December 2017

Pietro Tosca

6

1 reference

20 December 2017

publication date

14 November 2008

1 reference

20 December 2017

published in

Neurological Sciences

1 reference

20 December 2017

volume

29

1 reference

20 December 2017

issue

6

1 reference

20 December 2017

page(s)

417-423

1 reference

20 December 2017

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10072-008-1023-1

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-008-1023-1

Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-008-1023-1

Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-008-1023-1

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

21 January 2018

1 reference

12 December 2020

Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.

1 reference

12 December 2020

Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

1 reference

12 December 2020

Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values

1 reference

12 December 2020

Global prevalence of dementia: a Delphi consensus study

1 reference

12 December 2020

Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42.

1 reference

12 December 2020

Cerebrospinal fluid levels of total-tau, phospho-tau and A beta 42 predicts development of Alzheimer's disease in patients with mild cognitive impairment

1 reference

12 December 2020

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop

1 reference

12 December 2020

Cerebrospinal fluid biomarkers for disease stage and intensity in cognitively impaired patients

1 reference

12 December 2020

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

1 reference

12 December 2020

CSF markers for incipient Alzheimer's disease

1 reference

12 December 2020

Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease

1 reference

12 December 2020

CSF biomarkers for Alzheimer's Disease: levels of beta-amyloid, tau, phosphorylated tau relate to clinical symptoms and survival

1 reference

12 December 2020

1 reference

12 December 2020

Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work

1 reference

12 December 2020

Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study

1 reference

12 December 2020

Tau protein and the neurofibrillary pathology of Alzheimer's disease

1 reference

12 December 2020

Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies.

1 reference

12 December 2020

The pathology of "vascular dementia": a critical update

1 reference

12 December 2020

Both total and phosphorylated tau are increased in Alzheimer's disease

1 reference

12 December 2020

Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment.

1 reference

12 December 2020

Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease

1 reference

12 December 2020

Diagnostic accuracy of Alzheimer's disease: a clinicopathological study.

1 reference

12 December 2020

CSF biomarkers for mild cognitive impairment and early Alzheimer's disease

1 reference

12 December 2020

Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization.

1 reference

12 December 2020

Cerebrospinal fluid neurochemical phenotypes in vascular dementias: original data and mini-review

1 reference

12 December 2020

10.1007/S10072-008-1023-1

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017